AstraZeneca reports 88% emissions cut since 2015, crediting AI for accelerating drug discovery while embedding sustainability ...

Discusses Progress in Sustainability Strategy and the Role of AI in Healthcare Innovation July 6, 2026 9:30 AM ...

Abbisko will lead the study, with both companies jointly sharing clinical trial responsibilities.

AstraZeneca AZN and its Japan-based partner Daiichi Sankyo announced that the European Commission (EC) has approved their ...

AstraZeneca has partnered with YMCA of the USA (Y-USA) to increase awareness of cancer screening and early detection. Now in ...

AstraZeneca (LSE:AZN) is back in focus after a recent pullback, with the stock down about 5% over the past month and over the past 3 months, prompting investors to reassess its current valuation. See ...

Texas is recovering nearly $34 million from AstraZeneca to settle allegations that the pharmaceutical giant used an illegal ...

Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden.

July 2 (Reuters) - AstraZeneca has entered into a deal worth up to $1.77 billion with CSPC Pharmaceutical Group to discover and develop experimental medicines with the potential to treat kidney ...

AstraZeneca has impressed oncology patient groups, rising to second place on PatientView’s corporate reputation ranking on the back of strength in breast and lung cancer. | AstraZeneca has impressed ...

AstraZeneca has added another piece to its sprawling interface with CSPC Pharmaceutical, paying the Chinese biotech $30 million upfront to jointly discover and develop two kidney disease drug ...